Yellamandayya Vadlamudi

Synergistic therapy with tangeretin and 5-fluorouracil accelerates the ROS/JNK mediated apoptotic pathway in human colorectal cancer cell

Debasish Kumar Dey, Sukkum Ngullie Chang, Yellamandayya Vadlamudi et al. · Food and Chemical Toxicology · 2020 · 55 citations

Chemoprevention Strategy, Medicine, Pharmacology +7

Emerging Multi-cancer Regulatory Role of ESRP1: Orchestration of Alternative Splicing to Control EMT

Yellamandayya Vadlamudi, Debasish Kumar Dey, Sun Chul Kang · Current Cancer Drug Targets · 2020 · 23 citations

Cancer Biology, Multi-cancer Regulatory Role, Splicing Variant +16

Molecular modeling, dynamics, and an insight into the structural inhibition of cofactor independent phosphoglycerate mutase isoform 1 from<i>Wuchereria bancrofti</i>using cheminformatics and mutational studies

O. P. Sharma, Yellamandayya Vadlamudi, Qinghua Liao et al. · Journal of Biomolecular Structure and Dynamics · 2012 · 14 citations

Phosphoglycerate Mutase, Crystal Structure, Glycobiology +16

Structural exploration of acid sphingomyelinase at different physiological pH through molecular dynamics and docking studies

Yellamandayya Vadlamudi, K. Muthu, Suresh Kumar M. · RSC Advances · 2016 · 10 citations

Proteinlipid Interaction, Cellular Enzymology, Biochemistry +13

PTBP2 exon 10 inclusion is associated with the progression of CML and it is BCR-ABL1 dependent

S. Rajashree Nandagopalan, Agatheeswaran Subramaniam, Yellamandayya Vadlamudi et al. · The International Journal of Biochemistry & Cell Biology · 2019 · 10 citations